Group 1 - PepGen Inc. (NASDAQ: PEPG) has reported strong mean splicing correction data from its DM1 treatment in phase 1 trials, which is currently progressing to phase 2 [2] - The Value Lab focuses on long-only value investment ideas, aiming for a portfolio yield of approximately 4% and has seen success over the past five years by engaging in international markets [1] - The Valkyrie Trading Society consists of analysts sharing high conviction investment ideas that are downside limited and expected to yield non-correlated and outsized returns in the current economic environment [3]